Hey Vineet, Ya saw that in September Holdings earlier MK also invested through QIP at 570-575 levels and now he has added more I believe or just transferred, not sure.
Few Triggers:-
1- USFDA Lifting the Import Alert ban this would result in recovery in their formulations exports in US can bounce back drastically
2- Launch of their Recombinant Albumin Drug in which they have CONFIDENTLY invested also, there is shortage of this drug all over the world with Huge TAM. This product has a 9 billion$ market.
3- Easing of input costs in their API business which has already showed some signs in last quarter.
4- Launching of their Aflibercept – a complex product in the ophthalmic range. Starting phase-3 trials in India. Trying to develop this particular product for the global market.
5- They have started focusing on Deleveraging which will result in decreasing Interest cost and inflate profits and cash flows.
6- Capex cycle has been already been stopped apart from few small amt of capex left for Albumin.
7- They are also working on developing APIs which are now 100% imported so china+1 can work here.
8- R&D expense will be rationalized without compromising new developments. which will have a positive impact on P&L .
9- Overall company has strong pipeline for for ANDA, NBE which will be soon reflect in numbers.
Invested at 232-235 levels
| Subscribe To Our Free Newsletter |
